6-aminonicotinamide has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dwarakanath, BS; Sharma, PK; Varshney, R | 1 |
| Sharma, PK; Varshney, R | 1 |
2 other study(ies) available for 6-aminonicotinamide and Cancer of Head
| Article | Year |
|---|---|
Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells.
Topics: 6-Aminonicotinamide; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Deoxyglucose; Drug Synergism; Gamma Rays; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured | 2012 |
2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense.
Topics: 6-Aminonicotinamide; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Deoxyglucose; Down-Regulation; Glioma; Glutathione; Head and Neck Neoplasms; Humans; NF-E2-Related Factor 2; Protein Transport; Radiation-Sensitizing Agents; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Teratogens; Tumor Cells, Cultured | 2012 |